MedCity News June 20, 2021
This pandemic has shown that collaboration, biosimulation and decentralized trials, and active preparedness programs lead to fast, effective drug development when we really need it.
In response to Covid-19, the global drug development community has moved faster and further than ever before. But what have we learned from meeting this emergency? Players throughout the ecosystem, from drug developers to regulators, are considering how we can apply real-world lessons to benefit patients in the future.
While drug developers succeeded in rapid development of safe, effective vaccines, a lot of time and resources were wasted on projects that duplicated effort or disregarded existing science. Acting on lessons learned, and repurposing tools effectively used during this pandemic, will be critical in meeting...
Today's Sponsors
Today's Sponsor